FIGURE 13 A number of ruthenium(II) complexes described in these studies demonstrate noteworthy biological activities, including antimicrobial effects and micromolar cytotoxicity
From each included study, we extracted detailed information on the type and source of the bioactive compound, targeted cancer types, experimental models used ( in vitro, in vivo , or clinical), elucidated anticancer mechanisms, and any reported clinical efficacy or safety outcomes
Therefore, we finalized a policy for CY 2025 and subsequent years (89 FR 93932 through 93938), to not package payment for cell and gene therapies into C-APCs, when those cell and gene therapies are not functioning as integral, ancillary, supportive, dependent, or adjunctive to the primary C-APC service
Shadel GS, Horvath TL
J Mass Spectrom
Our structures of Cagri-AMYR-G s complexes allow direct examination of the influence of a C-terminal proline in an amylin-template peptide through comparison of the interactions formed by P37 Cagri to that of Y37 rAmy with the CTR and AMYRs